SSI Diagnostica

Executive Summary

SSI Diagnostica Group is a global leader in infectious disease diagnostics, offering in vitro diagnostic solutions for gastrointestinal, respiratory, and bloodborne diseases. With a portfolio of specialized brands, the company serves over 130 countries, delivering fast and accurate diagnostic tools that improve patient outcomes. Founded in 1990 and headquartered in Hillerød, Denmark, SSI Diagnostica operates as a private entity with 501-1000 employees. Its strong market presence and focus on innovation position it well for continued growth in the expanding diagnostics market, driven by increasing demand for rapid and reliable testing globally.

Upcoming Catalysts (preview)

• Q2 2026FDA or CE-IVDR approval for a new respiratory panel test70% success
• Q4 2026Strategic partnership with a major hospital network in Asia-Pacific60% success
• Q3 2026Launch of a next-generation gastrointestinal multiplex assay75% success